Prioritization of Therapy Options for a Patient With High Tumor Mutation Burden and Microsatellite Instability but No Clinical Benefit From Immunotherapy.

Nelson, Ryan S; Mehta, Rutika J; McLeod, Howard L; Walko, Christine M

Nelson, Ryan S; Mehta, Rutika J; McLeod, Howard L; Walko, Christine M.

Afiliación

Nelson RS; Moffitt Cancer Center, Tampa, FL.
Mehta RJ; Moffitt Cancer Center, Tampa, FL.
McLeod HL; Moffitt Cancer Center, Tampa, FL.
Walko CM; Moffitt Cancer Center, Tampa, FL.

JCO Precis Oncol ; 32019.

Article en En | MEDLINE | ID: mdl-32923851

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446362
https://dx.doi.org/10.1200/PO.19.00197

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2019 Tipo del documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446362
https://dx.doi.org/10.1200/PO.19.00197

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2019 Tipo del documento: Article